Search
for

    Sort by

    Research 271–300 of 647

    1. Association between prostate‐specific antigen and serum testosterone: A systematic review and meta‐analysis Andrology · 2020 · 11 citations
    2. Androgenetic alopecia and polymorphism of the androgen receptor gene (SNP rs6152) in patients with benign prostate hyperplasia or prostate cancer Journal of The European Academy of Dermatology and Venereology · 2014 · 11 citations
    3. Preventive Effects of Monascus on Androgen-Related Diseases: Androgenetic Alopecia, Benign Prostatic Hyperplasia, and Prostate Cancer Journal of Agricultural and Food Chemistry · 2013 · 11 citations
    4. Economic Issues in the Treatment of BPH European Urology Supplements · 2006 · 11 citations
    5. Estudio de patrones de implantación pilosa frontal en la mujer española caucásica Actas Dermo-Sifiliográficas · 2013 · 10 citations
    6. Abiraterone and spironolactone in prostate cancer: a combination to avoid Acta Clinica Belgica · 2018 · 9 citations
    7. Androgen Receptor Polymorphism-Dependent Variation in Prostate-Specific Antigen Concentrations of European Men Cancer Epidemiology, Biomarkers & Prevention · 2014 · 9 citations
    8. THERAPEUTIC HOTLINE: Treatment of androgenic alopecia with finasteride may result in a high grade prostate cancer in patients: fact or fiction? Dermatologic Therapy · 2010 · 9 citations
    9. Prostate-Specific Antigen as a Marker of Hyperandrogenism in Women and Its Implications for Antidoping Clinical Chemistry · 2016 · 8 citations
    10. 5-Alpha Reductase Inhibitors in Prostate Cancer: From Clinical Trials to Clinical Practice European Urology · 2013 · 7 citations
    11. Administration of Caesalpinia bonduc Seed Extracts Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia (BPH) in Male Wistar Rats Research and reports in urology · 2022 · 6 citations
    12. Interaction between estrogens and androgen receptor genes microsatellites, prostate-specific antigen and androgen receptor expressions in breast cancer Neoplasma · 2010 · 6 citations
    13. Three Considerations Before Advising 5-α-Reductase Inhibitors for Chemoprevention Journal of Clinical Oncology · 2009 · 6 citations
    14. Prostate cancer update: 2007 Current Opinion in Oncology · 2008 · 6 citations
    15. 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy Zenodo (CERN European Organization for Nuclear Research) · 2026 · 6 citations
    16. Long-Term Experience With 5-alpha-Reductase Inhibitors. PubMed · 2003 · 6 citations
    17. Inhibitory effects of TripTripterygium wilfordii multiglycoside on benign prostatic hyperplasia in rats 2015 · 5 citations
    18. Re: Androgenetic Alopecia as an Early Marker of Benign Prostatic Hyperplasia The Journal of Urology · 2012 · 5 citations
    19. Associations between sun sensitive pigmentary genes and serum prostate specific antigen levels PloS one · 2018 · 4 citations
    20. Patterns of Care for Newly Diagnosed Benign Prostatic Hyperplasia in the United States 2016 · 4 citations
    21. Hormonal treatment for male-pattern hair loss: implications for cancer of the prostate? BJUI · 2002 · 4 citations
    22. Evaluation of healthcare for transgender veterans Endocrine and metabolic science · 2020 · 3 citations
    23. Is there a relationship between androgenic alopecia and benign prostatic hyperplasia? DOAJ (DOAJ: Directory of Open Access Journals) · 2015 · 3 citations
    24. Doxazosin and finasteride alone or in combination: the PREDICT study BJUI · 2003 · 3 citations
    25. Effect of finasteride on prostate-specific antigen Lancet Oncology · 2006 · 2 citations
    26. Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?–Reply–II Mayo Clinic Proceedings · 2006 · 2 citations
    27. Comparison of combination therapy with tamsulosin and dutasteride or finasteride in patients with benign prostatic hyperplasia: a randomized clinical trial African Journal of Urology · 2024 · 1 citations
    28. Cervi Parvum Cornu complex for men with lower urinary tract symptoms: a multicenter, randomized, double-blind, placebo-controlled trial Prostate International · 2023 · 1 citations
    29. Role of serum androgens and prostate-specific antigen levels in men with androgenetic alopecia Egyptian Journal of Dermatology and Venereology · 2020 · 1 citations
    30. Serum androgens and prostate-specific antigen levels in androgenetic alopecia: is there a difference between frontal and vertex baldness? Journal of The European Academy of Dermatology and Venereology · 2017 · 1 citations